Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Br J Clin Pharmacol
; 86(9): 1836-1848, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32207164
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Macrophage Migration-Inhibitory Factors
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Br J Clin Pharmacol
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: